<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00763685</url>
  </required_header>
  <id_info>
    <org_study_id>35195</org_study_id>
    <secondary_id>EUDRACT 2008-004098-17</secondary_id>
    <nct_id>NCT00763685</nct_id>
  </id_info>
  <brief_title>Study to Evaluate the Efficacy of Pre-operative Administration of Etoricoxib 120 mg, Etoricoxib 120 mg and Paracetamol 1 g Combination or Placebo in the Treatment of Postoperative Pain in Patients Undergoing Gynaecologic Laparoscopic Surgery</brief_title>
  <official_title>Double-Blind, Randomized, Placebo -Controlled Study to Evaluate the Efficacy of Pre-operative Administration of Etoricoxib 120 mg, Etoricoxib 120 mg and Paracetamol 1 g Combination or Placebo in the Treatment of Postoperative Pain in Patients Undergoing Gynaecologic Laparoscopic Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>East Tallinn Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>East Tallinn Central Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Primary Hypothesis:

      1. The analgesic effect of etoricoxib 120 mg administered 1 hour preoperatively is greater
      than that of placebo in the treatment of postoperative pain.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    The gynecological laparoscopic surgery transition to day surgery made following the study
    protocol not possible.
  </why_stopped>
  <start_date>June 2010</start_date>
  <completion_date type="Actual">November 2011</completion_date>
  <primary_completion_date type="Actual">November 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain scale</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Vomiting</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>etoricoxib 120 mg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>active control</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Paracetamol 1 g and etoricoxib 120 mg</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>etoricoxib</intervention_name>
    <description>etoricoxib 120 mg, paracetamol 1 g</description>
    <arm_group_label>etoricoxib 120 mg</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Type of gynaecologic surgery:

               -  diagnostic laparoscopy

               -  sterilization

               -  removal of ovarial cyst

               -  chromopertubation

               -  laparoscopic myomectomy

               -  laparoscopic fenestration of ovaria

               -  laparoscopic adhesiolysis

          2. Age 18-50 years.

          3. Evaluated risk of anaesthetic procedure according to ASA (American Society of
             Anaesthesiologist) classification: ASA I or II.

          4. Patients agreed to participate in the study and signed the informed consent.

        Exclusion Criteria:

          1. ASA III or more

          2. Emergency surgery

          3. Major laparoscopic surgery i.e. hysterectomy

          4. Duration of surgery more than 90 minutes

          5. Chronic pain

          6. History of hypersensitivity to the active substance or to any of the excipients of
             study drug (Paracetamol or Etoricoxib)

          7. Active peptic ulceration or active gastro-intestinal (GI) bleeding.

          8. Patients who have experienced bronchospasm, acute rhinitis, nasal polyps,
             angioneurotic oedema, urticaria, or allergic-type reactions after taking
             acetylsalicylic acid or NSAIDs including COX-2 (cyclooxygenase-2) inhibitors.

          9. Pregnancy and lactation

         10. Severe hepatic dysfunction (serum albumin &lt; 25 g/l or Child-Pugh score ≥ 10).

         11. Estimated renal creatinine clearance &lt; 30 mL/min.

         12. Children and adolescents under 16 years of age.

         13. Inflammatory bowel disease.

         14. Congestive heart failure (NYHA II-IV).

         15. Patients with hypertension whose blood pressure has not been adequately controlled.

         16. Established ischaemic heart disease, peripheral arterial disease, and/or
             cerebrovascular disease, unstable angina.

         17. Patient has undergone coronary artery bypass graft surgery, angioplasty, or had
             myocardial infarction, cerebrovascular accident or transient ischemic attack within
             the past 6 months.

         18. History of drug abuse.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tiina Arumägi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>East Tallinn Central Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>East Tallinn Central Hospital</name>
      <address>
        <city>Tallinn</city>
        <zip>10138</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Estonia</country>
  </location_countries>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 30, 2008</study_first_submitted>
  <study_first_submitted_qc>September 30, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 1, 2008</study_first_posted>
  <last_update_submitted>January 29, 2012</last_update_submitted>
  <last_update_submitted_qc>January 29, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 31, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>East Tallinn Central Hospital</investigator_affiliation>
    <investigator_full_name>Tiina Arumagi</investigator_full_name>
    <investigator_title>anaesthesiologist</investigator_title>
  </responsible_party>
  <keyword>preoperative pain prophylaxis</keyword>
  <keyword>postoperative pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Etoricoxib</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

